PDCI Market Access | Canada’s Leading Pricing and Reimbursement Consultancy

We help Pharma / Biotech firms:

What's New

Subscribe to the C-MAP Canadian Drug Benefit Plans Reference Guide 2016 Edition today!

28

Sep

Alberta Releases New Amendments to Price Policy

26

Sep

Ontario Releases New Amendments to Regulation 201/96 under the ODBA Regulation and Regulation 935 under the DIDFA Regulation

20

Sep

Ontario Releases Updated Guidelines for Drug Submission and Evaluation 2016

13

Sep

Feedback on Proposed Revisions to Patient Input Template for CDR and pCODR

08

Sep

The pCPA: Negotiations Status Update

26

Aug

Registration is Underway for the CAHR Market Access 201 Course

26

Aug

PDCI Market Access WEBINAR ‒ Possible 2nd Session September 8, 2016 (date tentative)

19

Aug

PMPRB 2015 Annual Report Released

17

Aug

The pan-Canadian Pharmaceutical Alliance (pCPA): Negotiations Status Update

12

Aug

PDCI Market Access WEBINAR ‒ Information Session on the PMPRB Guidelines Modernization Discussion Paper

10

Aug

PDCI Market Access WEBINAR ‒ Information Session on the PMPRB Guidelines Modernization Discussion Paper

05

Aug

The PMPRB Releases its July 2016 NEWSletter

29

Jul

SAVE THE DATE

21

Jul

PMPRB 2015 Annual Report

12

Jul

The pan-Canadian Pharmaceutical Alliance (pCPA): Negotiations Status Update

04

Jul

PMPRB Guideline Modernization – PDCI to hold Industry Information Sessions in August / September

27

Jun

PMPRB – Discussion Paper Released – Board Down to 2 Board Members as of June 27 – 2015 Annual Report Board Delayed

20

Jun

PDCI Releases NEW Report on pCPA Best Practices, Trends and Outlook

03

Jun

BC PharmaCare Upcoming Modernization of the Reference Drug Program

01

Jun

RAMQ: June 2016 Update for the List of Medications

26

May

CADTH CDR and pCODR Engagement with the pCPA

25

May

Nova Scotia Pharmacare Funds INFLECTRA™ (infliximab)

18

May

The pan-Canadian Pharmaceutical Alliance (pCPA): Negotiations Status Update

17

May

CADTH Releases Recommendations Report for Anti-Vascular Endothelial Growth Factor Drugs for Retinal Conditions

03

May

The PMPRB Releases its April 2016 NEWSletter

03

May

Seeking Participation in the 2016 Private Payer PLA Survey

22

Apr

New Drug Review Process Developed by INESSS for Stable Blood Products

19

Apr

The pan-Canadian Pharmaceutical Alliance (pCPA) Releases its April 1st, 2016 Update

11

Apr

The pCPA Releases First Principles for Subsequent Entry Biologics

30

Mar

New Implementation Dates for Revisions to the Procedure for Voluntary Withdrawal and Providing CDR Review Team’s Responses

30

Mar

Minimum Period of 120 Calendar Days for Advance Notification of Anticipated Submissions and Resubmissions for CADTH’s CDR and pCODR Programs

24

Mar

The PMPRB to Implement Next Steps Regarding the Compendium of Policies, Guidelines and Procedures in June 2016

24

Mar

Ontario’s CED Will No Longer Routinely Evaluate CDR- or pCODR-Reviewed Drug Products

15

Mar

Ontario Public Drug Programs Funds INFLECTRA™ (infliximab)

15

Mar

CADTH Call for Patient Input for INFLECTRA™ (Subsequent Entry Biologic)

10

Mar

CADTH Call for Patient Input for Etanercept SEB

10

Mar

Proposal to Amend Ontario Regulation 201/96 under the Ontario Drug Benefit Act to Update Cost-Sharing Arrangements for Non-Low Income Seniors under the Ontario Drug Benefit Program

29

Feb

PDCI Pharmacare Costing Study Report 2016 – Final

26

Feb

Update on Procedures for the CADTH Common Drug Review and pan-Canadian Oncology Drug Review: Mandatory Disclosure of a Submitted Drug Price

23

Feb

pCPA February Update – Federal Drug Plans officially join the pCPA and the full Office team is now in place

17

Feb

Ontario Listing of Inflectra

17

Feb

Alexion pCPA Negotiation

12

Feb

Alberta Health Releases Price Confirmation Tentative Dates

12

Feb

PMPRB NEW Report: Generics360 – Generic Drugs in Canada, 2014

12

Feb

Modifications to the Procedure for Filing a Drug Submission Application for Generic Drugs with INESSS

02

Feb

New Pilot Initiative: Increasing Opportunities for Clinical Input and Feedback in CADTH pan-Canadian Oncology Drug Review Process

20

Jan

C-MAP™ Canadian Drug Benefit Plans Reference Guide 2016 Edition NOW AVAILABLE!

18

Jan

PHARMACARE COSTING IN CANADA: Preliminary Report

21

Dec

PMPRB Releases Strategic Plan 2015-2018

14

Dec

Patented Medicine Prices Review Board Releases 2014 Annual Report

14

Dec

Updates to the Guidelines for the Economic Evaluation of Health Technologies: Canada

14

Dec

Québec Moves to Introduce a Tendering System for Drugs

04

Dec

Ontario Releases Summary of Minister’s Roundtable on Pharmacare

01

Dec

Sherry O’Quinn Joins PDCI Market Access Inc.

25

Nov

PDCI Strategic Advice Services for Product Listing Agreements

13

Nov

PMPRB wins at Federal Court of Appeal – Maintains jurisdiction over patented generic products

12

Nov

PDCI’s Arvind Mani joins the Canadian Association for Healthcare Reimbursement (CAHR) Board of Directors

03

Nov

Presentation and Poll Results from PDCI Market Access Product Listing Agreement (PLA) Webinar is Now Available

26

Oct

CADTH: Extending Deadline on Consultation on Procedures for the CADTH Common Drug Review

26

Oct

CAHR National Day: National Approaches to Pharma Policy: International & Canadian Perspectives

20

Oct

PDCI Market Access WEBINAR ‒ Market Access Climate Change: the Evolving Impact of Product Listing Agreements

16

Oct

QUÉBEC: INESSS Upcoming Meetings with Manufacturers – June 2016 “Liste des médicaments”

16

Oct

pCPA October Update – Québec officially joins the pCPA & the pCPA Office is now operational

06

Oct

Expanding the CADTH Drug Review Process to Receive Patient Input Submissions from Individual Patients and Caregivers

30

Sep

Manulife DrugWatch™ & Private Payer Product Listing Agreement (PLA) Series

17

Sep

Private Payer Product Listing Agreement (PLA) Series

09

Sep

Private Payer Product Listing Agreement (PLA) Series

03

Sep

Private Payer Product Listing Agreement (PLA) Series

31

Jul

The PMPRB has released its July 2015 NEWSletter

27

Jul

Ontario Public Drug Programs Division

20

Jul

Exceptional Response to PDCI/H3 Private Payer PLA Survey

24

Jun

Private Payer PLA Survey

23

Jun

Australia’s Pharmaceutical Benefits Advisory Committee Recommends Substitution of Biosimilars

19

Jun

QUEBEC: INESSS Upcoming Meetings with Manufacturers – February 2016 “Liste des médicaments”

12

Jun

QUÉBEC – INESSS Submission Deadlines: 2015-2016

08

Jun

PDCI International Trends Series Part 5

27

May

BC: Updates to BC Drug Review Process and Submission Requirements

27

May

ON: Amendments to Ontario Regulation 201/96

26

May

PDCI International Trends Series Part 4

25

May

Canadian Organization for Rare Disorders (CORD) to release first ever Rare Disease Strategy

19

May

PDCI International Trends Series Part 3

14

May

PDCI International Trends Series Part 2

04

May

PDCI International Trends Series

10

Apr

WIB-Greater Montreal and the Technoparc Montréal Present a Conference on Drug Reimbursement in Quebec

10

Apr

Updates to the Manufacturer Submission Requirements in the Alberta Drug Benefit List (ADBL)

07

Apr

CADTH: Guidelines for Manufacturers on pCODR Application Fees Implemented

30

Mar

Rare Diseases Campaign

25

Mar

The pan-Canadian Oncology Drug Review (pCODR) is moving

25

Mar

PDCI Canadian Drug Claims Database FREE TRIAL now available!

12

Mar

CADTH Revised Category 1 Requirements for Tailored CDR Reviews

05

Mar

Guidelines for Manufacturers on Application Fees for pCODR

02

Mar

‘Successful CDR, pCODR & INESSS Submissions’ Workshop CANCELLED

23

Feb

Pan-Canadian Generics – Centralized Price Confirmation Process

09

Feb

Interview with pCPA on the Guidelines for Negotiations

04

Feb

CADTH Update for Patient Groups — January 2015

04

Feb

PMPRB Update – January 2015 NEWSletter

14

Jan

Drug products undergoing evaluation for the June 2015 “Liste des médicaments”

05

Jan

CDEC Final Recommendation for Inflectra Posted

22

Dec

Happy Holidays from PDCI!

14

Nov

PMPRB Has Released its October 2014 NEWSletter

06

Nov

Proposed Regulation Amendments to Establish a Pricing Framework for Generic Products

03

Nov

PDCI Career Opportunity

03

Nov

Voluntary Compliance Undertaking of Valeant Canada LP to PMPRB

24

Oct

Patented Medicines Prices Review Board (PMPRB) Outreach Sessions

22

Oct

Meetings with Manufacturers for the June 2015 “Liste des médicaments”

16

Oct

IBM “Pan Canadian Drugs Negotiation Report” Now Available

08

Oct

Welcome Anita!

07

Oct

PDCI Pan-Canadian Pharmaceutical Alliance (PCPA) Benchmarking Survey Report – NOW AVAILABLE!

03

Oct

CADTH Updates for Patient Groups

02

Oct

PMPRB: The PMPRB Launches its New Website

02

Oct

QUEBEC: October Update for the “Liste des médicaments”

18

Sep

PMPRB: New enhanced PMPRB website coming soon

16

Sep

PMPRB: 2013 Annual Report Released

16

Sep

CADTH: Revised Guidelines for Manufacturers on Application Fees

18

Aug

15th Anniversary Edition of the C-MAP™ Canadian Drug Benefit Plans Reference Guide

06

Aug

CADTH Direct-Acting Antivirals for Chronic Hepatitis C Genotype 1

05

Aug

PMPRB has released its July 2014 NEWSletter

31

Jul

CADTH: Feedback Requested on Industry Application Fee Guidelines

30

Jul

CADTH: CDR Update – Issue 106

29

Jul

New Brunswick: Rare diseases drug plan established

24

Jul

pCODR: Summary Report from Stakeholder Consultations on Transfer of pCODR to CADTH

09

Jul

PMPRB 2013 Annual Report Delayed

08

Jul

CADTH: CDR Update – Issue 105 – Patient Input

08

Jul

QUEBEC: INESSS to have meetings with manufacturers for February 2015 Liste des médicaments update

27

Jun

PMPRB Federal Court Decision Appealed

16

Jun

QUEBEC: Submission deadlines published

29

May

PMPRB jurisdiction does not extend to Generics (Federal Court Decisions)

27

May

Update on pCODR Procedures and Guidelines Consultation

26

May

CADTH: Common Drug Review (CDR) Update – Issue 104

25

May

Invitation to attend PMPRB Outreach sessions

24

May

Common Drug Review (CDR) introduces new application fee for submissions

23

May

The PMPRB releases the April 2014 issue of its NEWSletter

23

May

Québec: Update to the Liste de médicaments

22

May

CADTH: CDEC to review Drugs for Rare Diseases via “enhanced” CDR process

20

Mar

Subsequent Entry Biologics in Canada: Stakeholders Discuss the Regulatory, Pricing and Reimbursement Landscape.

20

Mar

Executive Briefing Pharmaceutical Pricing and Reimbursement in Canada 2012 Edition

20

Mar

National Pharmacare Cost Impact Study

20

Mar

Generic Drug Prices: A Canada US Comparison

20

Mar

Canada’s Balance of Trade in Pharmaceuticals

20

Mar

Parliamentary Review of Bill C-91: Background Study on Drug Costs and Benefits

18

Feb

Actual CPI in 2013 and implications for PMPRB price compliance

18

Feb

Second phase of generic pricing policy implemented yesterday

18

Feb

Premier Announces New Catastrophic Drug Coverage Program

18

Feb

Generic drug prices drop to 35 per cent of brand

18

Feb

Provincial government invests $2.4 million in health research

18

Feb

INESSS to have meetings with manufacturers for June 2014 Liste des médicaments update

18

Feb

Update to the Liste de médicaments

18

Feb

High-income seniors to pay more for drugs

18

Feb

Price for top 10 generic drugs cut to 20% of brand price

18

Feb

New drugs on formulary expected to save $10 million/year

18

Feb

Province announces it will reimburse 100% of the costs of oral cancer drugs

18

Feb

120 new drugs added to Pharmacare last month

18

Feb

Some seniors’ and children’s prescriptions to cost more

18

Feb

Online processing to help Saskatchewan-based travellers receive six-month supplies of drugs

18

Feb

Province introduces Pharmaceutical Services Act

18

Feb

Drug manufacturer submission deadlines for listing on the AHWDBL have been updated

18

Feb

18% Generic Drug Pricing Policy Effective March 15, 2013

18

Feb

CDR Update — Issue 98

18

Feb

Environmental Scan on Subsequent Entry Biologics released

18

Feb

CADTH to post patient input submissions as of February 1, 2014

18

Feb

Canadian Drug Expert Committee (CDEC) Meeting Schedule

18

Feb

Effective April 1 2014: pCODR is transferring to CADTH

14

Feb

New PDCI Study!

14

Feb

Effective April 1 2014: pCODR is transferring to CADTH

13

Feb

PMPRB

12

Feb

CADTH